CN100445427C - A kind of method for preparing titanium and titanium alloy glass-ceramic coating - Google Patents
A kind of method for preparing titanium and titanium alloy glass-ceramic coating Download PDFInfo
- Publication number
- CN100445427C CN100445427C CNB2005100480334A CN200510048033A CN100445427C CN 100445427 C CN100445427 C CN 100445427C CN B2005100480334 A CNB2005100480334 A CN B2005100480334A CN 200510048033 A CN200510048033 A CN 200510048033A CN 100445427 C CN100445427 C CN 100445427C
- Authority
- CN
- China
- Prior art keywords
- titanium
- glass
- coating
- titanium alloy
- glass ceramic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
本发明涉及一种制备钛及钛合金玻璃陶瓷涂层的方法,该方法所用玻璃陶瓷中,CaO和P2O5总含量在80~90mol%,Na2O的含量在4~7mol%,其余为TiO2和ZrO2。将原料混合均匀,经干燥后加热熔融,然后取出倒在不锈钢钢板上冲压制备玻璃,将冲压所得玻璃球磨成粉后,溶入甲醇配成浆液。将经氧化铝喷砂处理后的纯钛、Ti6Al4V、Ti29Nb13Ta4.6Zr和Ti24Nb4Zr7.6Sn合金浸入玻璃陶瓷甲醇混合溶液中浸提,然后高温烧结即得玻璃陶瓷涂层。该涂层不含SiO2,无有毒元素,具有良好的生物活性,在模拟人体体液中浸泡4天即有羟基磷灰石生成,其与钛及钛合金基体的结合力大于15MPa。该涂层具有较高的Ca/P比以及和人体硬组织相似的成分,可以更快地诱导植入体表面新骨的生长,可以作为人体硬组织替代和修复材料。The invention relates to a method for preparing titanium and titanium alloy glass-ceramic coatings. In the glass-ceramics used in the method, the total content of CaO and P2O5 is 80-90mol% , the content of Na2O is 4-7mol%, and the rest For TiO 2 and ZrO 2 . Mix the raw materials evenly, heat and melt after drying, then take them out and pour them on the stainless steel plate to punch to prepare glass, grind the punched glass balls into powder, dissolve them in methanol to make a slurry. The pure titanium, Ti6Al4V, Ti29Nb13Ta4.6Zr and Ti24Nb4Zr7.6Sn alloys treated by alumina blasting are immersed in the mixed solution of glass ceramics and methanol for extraction, and then sintered at high temperature to obtain the glass ceramic coating. The coating does not contain SiO 2 , no toxic elements, and has good biological activity. Hydroxyapatite will be formed after soaking in simulated human body fluid for 4 days, and its binding force with titanium and titanium alloy substrate is greater than 15MPa. The coating has a high Ca/P ratio and a composition similar to that of human hard tissue, which can induce the growth of new bone on the surface of the implant faster, and can be used as a replacement and repair material for human hard tissue.
Description
技术领域: Technical field:
本发明涉及生物涂层领域和玻璃陶瓷领域,特别是涉及钛及钛合金作为硬组织修复和替代材料时表面活性涂层制备领域,具体为一种制备钛及钛合金玻璃陶瓷涂层的方法。The invention relates to the fields of biological coatings and glass ceramics, in particular to the field of preparation of surface active coatings when titanium and titanium alloys are used as hard tissue repair and replacement materials, specifically a method for preparing titanium and titanium alloy glass ceramic coatings.
背景技术: Background technique:
在发达国家,关节炎及骨折是导致老年人无法行走的主要原因之一。在日本,置换人工股关节及人工膝关节手术每年就达10万例,因此市场开发具有长期稳定质量的人工关节及人工骨具有重要的意义。见参考文献[1]:李青.钛合金表面涂层应用于生物骨的研究.生物骨科材料与临床研究.2004,1[3]:45-49。钛及钛合金因其优良的力学性能、抗腐蚀性能和良好的生物相容性成为重要的硬组织修复和替代材料。然而钛及钛合金属于生物惰性材料,其作为种植体直接植入时,表面会被生物体的胶原蛋白包围,将种植体与生物骨隔离,长期植入容易引起松动,难以与生物骨形成牢固结合。人工种植体与生物骨形成骨结合的必要条件是:人工种植体在生物体内,其表面要形成与骨组织类似的磷灰石。人工种植体表面一旦形成了与生物骨组织类似的磷灰石,生物体细胞就不能识别出它是异物,而将其视为生物骨的同类并与损伤的生物骨一起生长,在表面上快速地种植骨芽细胞,生物骨的磷灰石与人工种植体表面的磷灰石之间就形成了牢固的化学结合,最后与生物骨成为一体。见参考文献[2]:L.L.Hench,R.J.Splinter,W.C.Allen and T.K.Greenlee.Bonding mechanisms at the interface of ceramic prosthetic materials.Journalof Biomedical Materials Research Symposium.1971,2:117-141。研究发现,45S5生物玻璃(Na2O-CaO-SiO2-P2O5系)、Ceravital微晶玻璃(Na2O-K2O-MgO-CaO-P2O5-SiO2系)、A-W生物玻璃陶瓷(MgO-CaO-SiO2-P2O5系)、羟基磷灰石生物活性陶瓷(HA,组成为:Ca10(PO4)6(OH)2)等等植入生物体内,不会被纤维性膜包覆,能于骨形成牢固结合。见参考文献[3]:L.L.Hench.Bioceramics.Journal of American Ceramics Society.1998,81[7]:1705-1728。因此,如果能在钛及钛合金表面制备一层生物玻璃陶瓷涂层,则既能发挥金属优良的力学性能,又使表面具有生物相容性和生物活性等特点。等离子喷涂羟基磷灰石是临床上常用的制备活性涂层的方法。但是,等离子喷涂在高温下进行,涂层成分和晶体结构难于控制,并且设备要求高,成本昂贵,长期植入,有松动的倾向。见参考文献[4]:F.Li,Q.L.FengZ.Cui,H.D.Li and H.Schubert.A simple biomimeticmethod for calcium phosphate coating.Surface and Coatings Technology,2002,154:88-93。In developed countries, arthritis and fractures are one of the main reasons why the elderly cannot walk. In Japan, there are 100,000 cases of artificial hip joint replacement and artificial knee joint surgery every year. Therefore, it is of great significance to develop artificial joints and artificial bones with long-term stable quality in the market. See reference [1]: Li Qing. Titanium alloy surface coating applied to the study of biological bone. Bio-orthopedic materials and clinical research. 2004, 1[3]: 45-49. Titanium and titanium alloys have become important hard tissue repair and replacement materials due to their excellent mechanical properties, corrosion resistance and good biocompatibility. However, titanium and titanium alloys are biologically inert materials. When they are directly implanted as implants, the surface will be surrounded by biological collagen, which will isolate the implant from the biological bone. Long-term implantation will easily cause loosening, and it is difficult to form a firm structure with the biological bone. combined. The necessary condition for osseointegration of artificial implant and biological bone is that the surface of the artificial implant should form apatite similar to bone tissue in the living body. Once the apatite similar to the biological bone tissue is formed on the surface of the artificial implant, the biological cells will not be able to recognize it as a foreign body, but will regard it as the same kind of biological bone and grow together with the damaged biological bone, rapidly growing on the surface. Bone bud cells are implanted in the ground, and a firm chemical bond is formed between the apatite of the biological bone and the apatite on the surface of the artificial implant, and finally become one with the biological bone. See reference [2]: LL Hench, RJSplinter, WCAllen and TKGreenlee. Bonding mechanisms at the interface of ceramic prosthetic materials. Journal of Biomedical Materials Research Symposium. 1971, 2: 117-141. The study found that 45S5 Bio-glass (Na 2 O-CaO-SiO 2 -P 2 O 5 series), Ceravital glass-ceramics (Na 2 OK 2 O-MgO-CaO-P 2 O 5 -SiO 2 series), AW bio-glass ceramics (MgO -CaO-SiO 2 -P 2 O 5 series), hydroxyapatite bioactive ceramics (HA, composed of: Ca 10 (PO 4 ) 6 (OH) 2 ), etc. implanted in the body, will not be affected by fibrous Covered by a membrane, it can form a firm bond with the bone. See reference [3]: LL Hench. Bioceramics. Journal of American Ceramics Society. 1998, 81 [7]: 1705-1728. Therefore, if a layer of biological glass-ceramic coating can be prepared on the surface of titanium and titanium alloys, it can not only exert the excellent mechanical properties of the metal, but also make the surface have the characteristics of biocompatibility and bioactivity. Plasma spraying of hydroxyapatite is a commonly used method for preparing active coatings in clinical practice. However, plasma spraying is carried out at high temperature, and the composition and crystal structure of the coating are difficult to control, and the equipment requirements are high, the cost is high, and the long-term implantation tends to loosen. See reference [4]: F.Li, QLFeng Z. Cui, HDLi and H. Schubert. A simple biomimetic method for calcium phosphate coating. Surface and Coatings Technology, 2002, 154: 88-93.
本发明建立在已有的玻璃陶瓷基础上(专利申请号:200510047283.6,申请曰:2005.9.28),采用简单的工艺,廉价的设备在钛及钛合金表面制备了玻璃陶瓷涂层。该玻璃陶瓷涂层不含SiO2,无有毒元素,具有良好的生物活性。同时,该涂层具有较高的Ca/P比以及和人体硬组织相似的成分,可以作为人体硬组织替代和修复材料。该涂层作为植入体植入时,可望发挥钛及钛合金优良的力学性质和涂层良好的生物活性,可望更快更强地引导新骨的生长。The present invention is based on the existing glass ceramics (patent application number: 200510047283.6, application date: 2005.9.28), and prepares glass ceramic coatings on the surface of titanium and titanium alloys with simple technology and cheap equipment. The glass ceramic coating does not contain SiO 2 , no toxic elements, and has good biological activity. At the same time, the coating has a high Ca/P ratio and a composition similar to that of human hard tissue, and can be used as a replacement and repair material for human hard tissue. When the coating is implanted as an implant, it is expected to exert the excellent mechanical properties of titanium and titanium alloys and the good biological activity of the coating, and is expected to guide the growth of new bone faster and stronger.
发明内容: Invention content:
本发明的目的是提供一种制备钛及钛合金玻璃陶瓷涂层的方法。采用该方法获得的涂层不含SiO2,无有毒元素,具有良好的生物活性,它和人体硬组织具有相似的成分,可以作为人体组织替代和修复材料。The purpose of the present invention is to provide a method for preparing titanium and titanium alloy glass ceramic coating. The coating obtained by this method does not contain SiO 2 , no toxic elements, and has good biological activity. It has similar components to human hard tissues and can be used as a Tissue replacement and restorative materials.
本发明的技术方案是:Technical scheme of the present invention is:
本发明提供一种制备钛及钛合金玻璃陶瓷涂层的方法,涂层的制备包括玻璃陶瓷粉末的制备、钛及钛合金预处理及涂层的涂覆和烧结,具体步骤如下:The invention provides a method for preparing a titanium and titanium alloy glass-ceramic coating. The preparation of the coating includes the preparation of glass-ceramic powder, titanium and titanium alloy pretreatment, and coating and sintering of the coating. The specific steps are as follows:
(1)玻璃陶瓷粉末的制备(1) Preparation of glass ceramic powder
所用玻璃陶瓷为CaO-P2O5-Na2O-TiO2-ZrO2玻璃陶瓷粉末,玻璃陶瓷粉末的组成为:CaO和P2O5总含量在80~90mol%,Na2O的含量在4~7mol%,其余为TiO2和ZrO2,Ca与P摩尔比为0.5~1.5,ZrO2的含量在0.5~10mol%;以CaCO3,Na2CO3,TiO2,ZrO2和H3PO4为原料,按所述成分将原料混合均匀,配制玻璃浆液,经干燥后捣碎成5~10μm粉,加热到1300~1400℃熔融并保温,保温时间为0.5~1小时;然后取出倒在不锈钢钢板上冲压得玻璃陶瓷,将所得玻璃球磨成1~10μm粉即得玻陶瓷粉末;The glass ceramic used is CaO-P 2 O 5 -Na 2 O-TiO 2 -ZrO 2 glass ceramic powder, the composition of the glass ceramic powder is: the total content of CaO and P 2 O 5 is 80-90 mol%, and the content of Na 2 O 4~7mol%, the rest is TiO 2 and ZrO 2 , the molar ratio of Ca to P is 0.5~1.5, and the content of ZrO 2 is 0.5~10mol%; CaCO 3 , Na 2 CO 3 , TiO 2 , ZrO 2 and H 3. PO 4 is the raw material. Mix the raw materials evenly according to the above ingredients, prepare glass slurry, grind it into 5-10 μm powder after drying, heat it to 1300-1400 ° C to melt and keep it warm for 0.5-1 hour; then take it out Pour it on a stainless steel plate and punch it to get glass ceramics, and grind the obtained glass balls into 1-10 μm powder to get glass ceramics. ceramic powder;
(2)钛及钛合金预处理(2) Titanium and titanium alloy pretreatment
将钛及钛合金合金经氧化铝喷砂处理,达到表面粗糙度为1~5μm;Titanium and titanium alloys are subjected to alumina blasting treatment to achieve a surface roughness of 1-5 μm;
(3)涂层的涂覆和烧结(3) Coating and sintering of the coating
将球磨所得玻璃陶瓷粉末配成甲醇浆液,将喷砂处理后的钛及钛合金完全浸入,然后浸提,在空气中自然干燥后在电阻炉内烧结。The glass-ceramic powder obtained by ball milling is made into methanol slurry, and the sandblasted titanium and titanium alloys are completely immersed, then extracted, dried naturally in the air, and then sintered in a resistance furnace.
所述玻璃陶瓷甲醇溶液浓度为0.01~2M,浸提速度为0.5~5mm/s,烧结温度分别为700~900℃,烧结时间为0.5~3小时。The glass ceramics methanol solution has a concentration of 0.01-2M, an extraction speed of 0.5-5mm/s, a sintering temperature of 700-900°C and a sintering time of 0.5-3 hours.
本发明钛及钛合金采用纯钛、Ti6Al4V、Ti29Nb13Ta4.6Zr或Ti24Nb4Zr7.6Sn。The titanium and titanium alloys of the present invention adopt pure titanium, Ti6Al4V, Ti29Nb13Ta4.6Zr or Ti24Nb4Zr7.6Sn.
采用本发明方法制备的涂层经700℃、800℃和900℃烧结后主要成分是β-Ca3(PO4)2和β-Ca2P2O7。The main components of the coating prepared by the method of the invention are β-Ca 3 (PO 4 ) 2 and β-Ca 2 P 2 O 7 after being sintered at 700°C, 800°C and 900°C.
采用本发明方法制备的涂层具有良好的生物活性,在模拟人体体液(SBF)中浸泡4天即有羟基磷灰石生成。The coating prepared by the method of the invention has good biological activity, and hydroxyapatite can be formed after soaking in simulated human body fluid (SBF) for 4 days.
采用本发明方法制备的涂层与钛及钛合金基体结合力大于15MPa。The bonding force between the coating prepared by the method of the invention and the titanium and titanium alloy substrate is greater than 15MPa.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明玻璃陶瓷涂层不含SiO2,无有毒元素,具有良好的生物活性,在模拟人体体液中浸泡4天即有羟基磷灰石生成;该涂层与钛及钛合金基体具有较高结合力(大于15MPa)。该涂层具有较高的Ca/P比以及和人体硬组织相似的成分,可以作为人体硬组织替代和修复材料。该涂层作为植入体植入时,可望发挥钛及钛合金优良的力学性质和涂层良好的生物活性,可望更快更强地引导新骨的生长。The glass-ceramic coating of the present invention does not contain SiO 2 , no toxic elements, and has good biological activity. Hydroxyapatite will be formed after soaking in simulated human body fluid for 4 days; the coating has a high bond with titanium and titanium alloy substrates Force (greater than 15MPa). The coating has a high Ca/P ratio and a composition similar to that of human hard tissue, and can be used as a replacement and repair material for human hard tissue. When the coating is implanted as an implant, it is expected to exert the excellent mechanical properties of titanium and titanium alloys and the good biological activity of the coating, and is expected to guide the growth of new bone faster and stronger.
附图说明: Description of drawings:
图1玻璃粉2#在喷砂后的纯钛表面涂覆并在700℃烧结后实物形貌;Figure 1 The physical appearance of glass powder 2# coated on the surface of pure titanium after sandblasting and sintered at 700 °C;
图2玻璃粉2#在喷砂后的纯钛表面涂覆并在700℃烧结后表面X-射线衍射图谱;Figure 2 The surface X-ray diffraction pattern of glass powder 2# coated on the surface of pure titanium after sandblasting and sintered at 700 ° C;
图3玻璃粉4#在喷砂后的Ti6Al4V合金片表面涂覆并在900℃烧结后表面X-射线衍射图谱;Figure 3 Glass powder 4# is coated on the surface of the Ti6Al4V alloy sheet after sandblasting and sintered at 900 ° C and the surface X-ray diffraction pattern;
图4玻璃粉9#在喷砂后的Ti24Nb4Zr7.6Sn合金片表面涂覆并在800℃烧结后表面X-射线衍射图谱;Fig. 4 The surface X-ray diffraction pattern of glass powder 9# coated on the surface of the Ti24Nb4Zr7.6Sn alloy sheet after sandblasting and sintered at 800 °C;
图5玻璃粉9#在喷砂后的Ti24Nb4Zr7.6Sn合金片表面涂覆并在800℃烧结的表面形貌图;Figure 5 is the surface topography of glass powder 9# coated on the surface of the Ti24Nb4Zr7.6Sn alloy sheet after sandblasting and sintered at 800 °C;
图6玻璃粉9#在喷砂后的Ti24Nb4Zr7.6Sn合金片表面涂覆并在800℃烧结然后在模拟人体体液(SBF)中浸泡4天后的表面形貌图;Figure 6 is the surface topography of glass powder 9# coated on the surface of the Ti24Nb4Zr7.6Sn alloy sheet after sandblasting and sintered at 800 ° C and then soaked in simulated human body fluid (SBF) for 4 days;
图7玻璃粉3#在喷砂后的Ti29Nb13Ta4.6Zr合金片表面涂覆并在800℃烧结然后在模拟人体体液(SBF)中浸泡4天后的表面形貌图;Figure 7 is the surface topography of glass powder 3# coated on the surface of the Ti29Nb13Ta4.6Zr alloy sheet after sandblasting and sintered at 800 ° C and then soaked in simulated human body fluid (SBF) for 4 days;
图8玻璃粉3#在喷砂后的Ti29Nb13Ta4.6Zr合金片表面涂覆并在800℃烧结然后在模拟人体体液(SBF)中浸泡4天后的表面X-射线衍射图谱。Figure 8 is the surface X-ray diffraction pattern of glass powder 3# coated on the surface of Ti29Nb13Ta4.6Zr alloy sheet after sandblasting, sintered at 800°C and soaked in simulated human body fluid (SBF) for 4 days.
具体实施方式: Detailed ways:
实施例1Example 1
用分析纯CaCO3,Na2CO3,TiO2,ZrO2和H3PO4(重量浓度85%)为原料配制按表1所述1~10#成分玻璃浆液,用电动搅拌机将原料混合均匀,然后置于50℃干燥箱内干燥24h。将干燥后原料捣成粉末(粒度为5-10μm)置于铂金坩埚内在1350℃保温0.5h,立即取出倒在不锈钢钢板上并快速冲压即得玻璃。Use analytically pure CaCO 3 , Na 2 CO 3 , TiO 2 , ZrO 2 and H 3 PO 4 (weight concentration 85%) as raw materials to prepare glass slurry with ingredients 1 to 10# as described in Table 1, and use an electric mixer to mix the raw materials evenly , and then placed in a 50°C drying oven for 24 hours. Pound the dried raw material into powder (with a particle size of 5-10 μm) and place it in a platinum crucible at 1350°C for 0.5h, take it out immediately, pour it on a stainless steel plate, and press it quickly to obtain glass.
表1CaO-P2O5-Na2O-TiO2-ZrO2玻璃成份Table 1CaO-P 2 O 5 -Na 2 O-TiO 2 -ZrO 2 glass components
实施例2Example 2
将所得玻璃2#球磨成粉(粒度为1~10μm)。将玻璃陶瓷粉配成0.01M甲醇浆液,纯钛棒经粒径为0.5mm氧化铝喷砂处理(表面粗糙度为1μm)后用细线悬挂置入,以1mm/s速度上提,在空气中自然干燥后在700℃电阻炉保温1小时,随炉冷却。实物宏观图象如图1所示,其涂层表面X-射线衍射图谱如图2所示。The obtained glass 2# is ball-milled into powder (with a particle size of 1-10 μm). The glass-ceramic powder is made into 0.01M methanol slurry, and the pure titanium rod is sandblasted with alumina with a particle size of 0.5mm (surface roughness is 1μm), and then suspended with a thin wire, lifted at a speed of 1mm/s, and placed in the air. After natural drying in medium temperature, keep it in a resistance furnace at 700°C for 1 hour, and then cool down with the furnace. The macro image of the real object is shown in Figure 1, and the X-ray diffraction pattern of the coating surface is shown in Figure 2.
实施例3Example 3
将所得玻璃4#球磨成粉(粒度为1~10μm)。将玻璃陶瓷粉配成2M甲醇浆液,Ti6Al4V合金片经粒径为3mm氧化铝喷砂处理(表面粗糙度为5μm)后用细线悬挂置入,以5mm/s速度上提,在空气中自然干燥后在900℃电阻炉保温1小时,随炉冷却。其涂层表面X-射线衍射图谱如图3所示。The obtained glass 4# is ball-milled into powder (with a particle size of 1-10 μm). The glass ceramic powder is made into 2M methanol slurry, the Ti6Al4V alloy sheet is sandblasted with alumina with a particle size of 3mm (surface roughness is 5μm), and then suspended with a thin wire, lifted at a speed of 5mm/s, and naturally in the air After drying, keep it in a resistance furnace at 900°C for 1 hour, and then cool down with the furnace. The X-ray diffraction pattern of the coating surface is shown in Figure 3.
实施例4Example 4
将所得玻璃9#球磨成粉(粒度为1~10μm)。将玻璃陶瓷粉配成0.05M甲醇浆液,Ti24Nb4Zr7.6Sn合金片经粒径为2mm氧化铝喷砂处理(表面粗糙度为2.5μm)后用细线悬挂置入,以2mm/s速度上提,在空气中自然干燥后在800℃电阻炉保温1小时,随炉冷却。其涂层表面X-射线衍射图谱如图4所示。The obtained glass 9# is ball-milled into powder (with a particle size of 1-10 μm). The glass ceramic powder is made into 0.05M methanol slurry, and the Ti24Nb4Zr7.6Sn alloy sheet is sandblasted with alumina with a particle size of 2mm (surface roughness is 2.5μm), then suspended with a thin wire, and lifted at a speed of 2mm/s. After natural drying in the air, keep it in an 800°C resistance furnace for 1 hour, and then cool down with the furnace. The X-ray diffraction pattern of the coating surface is shown in Figure 4.
实施例5Example 5
将实施例4所得玻璃陶瓷涂层在模拟人体体液(表2)中37℃浸泡4天后,表面有羟基磷灰石生成。其浸泡前微观形貌如图5所示,浸泡后微观形貌如图6所示。After soaking the glass-ceramic coating obtained in Example 4 in simulated human body fluid (Table 2) at 37° C. for 4 days, hydroxyapatite was formed on the surface. The microscopic appearance before soaking is shown in Figure 5, and the microscopic appearance after soaking is shown in Figure 6.
表2人体中的血浆和模拟人体体液(SBF)中的离子浓度(mM)Table 2 Ion concentrations (mM) in plasma and simulated body fluid (SBF) in the human body
实施例6Example 6
将所得玻璃3#球磨成粉(粒度为1~10μm)。将玻璃陶瓷粉配成0.05M甲醇浆液,Ti29Nb13Ta4.6Zr合金片经粒径为2mm氧化铝喷砂处理(表面粗糙度为2.5μm)后用细线悬挂置入,以1mm/s速度上提,在空气中自然干燥后在800℃电阻炉保温1小时,随炉冷却。然后在模拟人体体液(表2)中37℃浸泡4天后,表面有羟基磷灰石生成,其形貌如图7示,表面X-射线衍射图谱如图8所示。The obtained glass 3# is ball-milled into powder (with a particle size of 1-10 μm). The glass ceramic powder is made into 0.05M methanol slurry, and the Ti29Nb13Ta4.6Zr alloy sheet is sandblasted with alumina with a particle size of 2mm (surface roughness is 2.5μm), and then suspended with a thin wire, and lifted at a speed of 1mm/s. After natural drying in the air, keep it in an 800°C resistance furnace for 1 hour, and then cool down with the furnace. Then, after soaking in simulated human body fluid (Table 2) at 37°C for 4 days, hydroxyapatite was formed on the surface, the morphology of which is shown in Figure 7, and the surface X-ray diffraction pattern is shown in Figure 8.
实施例7Example 7
将Ti24Nb4Zr7.6Sn合金加工成5×5×30mm试样,经1mm氧化铝喷砂处理(表面粗糙度为1.5μm)后用细线悬挂置入0.05M成分为2#的玻璃陶瓷浆液中,以2mm/s速度上提,在空气中自然干燥后在800℃电阻炉保温1小时,随炉冷却。涂层面与相同尺寸的不锈钢钢用环氧树脂E-44粘结固化。该试样在MTS拉伸实验机测试,断裂强度为15MPa,断裂发生在环氧树脂一侧。The Ti24Nb4Zr7.6Sn alloy was processed into a 5×5×30mm sample, which was sandblasted with 1mm alumina (with a surface roughness of 1.5μm) and suspended with a thin wire into a 0.05M glass-ceramic slurry with a composition of 2#. Lift at a speed of 2mm/s, dry naturally in the air and keep warm in a resistance furnace at 800°C for 1 hour, then cool with the furnace. The coated surface is bonded to stainless steel of the same size and cured with epoxy resin E-44. The sample was tested on the MTS tensile testing machine, the breaking strength was 15MPa, and the breaking occurred on the side of the epoxy resin.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100480334A CN100445427C (en) | 2005-12-16 | 2005-12-16 | A kind of method for preparing titanium and titanium alloy glass-ceramic coating |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100480334A CN100445427C (en) | 2005-12-16 | 2005-12-16 | A kind of method for preparing titanium and titanium alloy glass-ceramic coating |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1982504A CN1982504A (en) | 2007-06-20 |
CN100445427C true CN100445427C (en) | 2008-12-24 |
Family
ID=38165335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100480334A Expired - Fee Related CN100445427C (en) | 2005-12-16 | 2005-12-16 | A kind of method for preparing titanium and titanium alloy glass-ceramic coating |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100445427C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI477388B (en) * | 2012-07-04 | 2015-03-21 | Darfon Materials Corp | Method of fabricating casing and casing therefrom |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100587115C (en) * | 2007-12-27 | 2010-02-03 | 南京航空航天大学 | Hydrogen permeable self-stripping vitreous coating for titanium or titanium alloy and preparation method thereof |
CN101618230B (en) * | 2008-07-01 | 2013-03-27 | 叶南辉 | Method for manufacturing biomedical glass ceramic material |
CN101884807B (en) * | 2010-06-24 | 2013-06-26 | 同济大学 | A kind of preparation method and application of borate glass antibacterial coating with biological activity |
CN102230100B (en) * | 2011-07-01 | 2013-03-06 | 湖南科技大学 | Method for preparing Ti-Nb-Zr-Sn alloy by using powder metallurgical process |
CN102886072A (en) * | 2012-10-09 | 2013-01-23 | 天津大学 | Degraded glass ceramic thin film for medical magnesium alloy surface and preparation method of degraded glass ceramic thin film |
CN103469207B (en) * | 2013-08-16 | 2015-06-03 | 中国科学院金属研究所 | High-temperature oxidation resistant and corrosion resistant glass ceramic composite coating and preparation technology thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178901A (en) * | 1989-12-02 | 1993-01-12 | Agency Of Industrial Science & Technology | Titanium metal-coating material, method for production thereof, method for coating therewith, and product coated therewith |
US5196381A (en) * | 1990-01-16 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Metaphosphate glass composition |
US6130178A (en) * | 1998-04-16 | 2000-10-10 | Corning Incorporated | Strong miserite glass-ceramics |
-
2005
- 2005-12-16 CN CNB2005100480334A patent/CN100445427C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178901A (en) * | 1989-12-02 | 1993-01-12 | Agency Of Industrial Science & Technology | Titanium metal-coating material, method for production thereof, method for coating therewith, and product coated therewith |
US5196381A (en) * | 1990-01-16 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Metaphosphate glass composition |
US6130178A (en) * | 1998-04-16 | 2000-10-10 | Corning Incorporated | Strong miserite glass-ceramics |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI477388B (en) * | 2012-07-04 | 2015-03-21 | Darfon Materials Corp | Method of fabricating casing and casing therefrom |
Also Published As
Publication number | Publication date |
---|---|
CN1982504A (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cao et al. | Bioactive materials | |
Vitale-Brovarone et al. | Bioactive glass-derived trabecular coating: a smart solution for enhancing osteointegration of prosthetic elements | |
Hench | Bioceramics: from concept to clinic | |
Ou et al. | Preparation and in vitro bioactivity of novel merwinite ceramic | |
WO2007124511A2 (en) | Resorbable ceramics with controlled strength loss rates | |
US20110195378A1 (en) | Composite Bio-Ceramic Dental Implant and Fabricating Method Thereof | |
Araújo et al. | Glass coatings on zirconia with enhanced bioactivity | |
Baino et al. | Novel full-ceramic monoblock acetabular cup with a bioactive trabecular coating: Design, fabrication and characterization | |
Bellucci et al. | Bioactive glass/ZrO2 composites for orthopaedic applications | |
CN100445427C (en) | A kind of method for preparing titanium and titanium alloy glass-ceramic coating | |
EP2211920B1 (en) | Biocompatible material and uses thereof | |
Nakamura et al. | Bioactive ceramics: past and future | |
Prasad et al. | Preparation, in-vitro bioactivity and mechanical properties of reinforced 45s5 bioglass composite with HA-ZRO2 powders | |
CN101618230B (en) | Method for manufacturing biomedical glass ceramic material | |
Baino et al. | Novel bone-like porous glass coatings on Al2O3 prosthetic substrates | |
CN100406069C (en) | A kind of CaO-P2O5-Na2O-TiO2-ZrO2 biological glass ceramics and its preparation method | |
Baino et al. | Trabecular coating on curved alumina substrates using a novel bioactive and strong glass-ceramic | |
Al-Haidary et al. | Effect of yttria addition on mechanical, physical and biological properties of bioactive MgO–CaO–SiO2–P2O5–CaF2 glass ceramic | |
Gunduz et al. | Reinforcing of biologically derived apatite with commercial inert glass | |
CN1754852A (en) | A machinable bioactive glass-ceramic and its preparation method | |
Bafandeh et al. | Characterization of fabricated cobalt-based alloy/nano bioactive glass composites | |
Gadallah et al. | Biomimetic Coating of Titanium Surface Using Bioactive Glass Nanoparticles. | |
US20100154681A1 (en) | Method for manufacturing biomedical bone filler with concrete characteristic | |
Li et al. | Calcium phosphate formation induced on silica in bamboo | |
Anene et al. | Evaluation of Corrosion Inhibition of Plasma Sprayed FsHA/YSZ Coating on β-Titanium (Ti-13Nb-13Zr) Alloy Using Electrochemical Techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081224 Termination date: 20141216 |
|
EXPY | Termination of patent right or utility model |